Manufacturer copay assistance · Avastin (J9035) · Genentech
Eligible patients pay as… · Maximum benefit Up to $25,000/year · Covers Avastin drug cost only — does NOT cover infusion administration
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Avastin — the program's cap applies against the patient share CareCost calculates.
Yes — Genentech Oncology Co-pay Assistance Program (Avastin) from Genentech. Eligible patients pay as little as $0 per fill. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients pay as little as $0 per fill Maximum benefit: Up to $25,000/year. Covers Avastin drug cost only — does NOT cover infusion administration
Accepted insurance: commercial. Not eligible: medicare, medicaid, tricare, va, government.